IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

[1]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[2]  H. Schreiber,et al.  Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.

[3]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[4]  S. Thorgeirsson,et al.  Regulation of α-Fetoprotein by Nuclear Factor-κB Protects Hepatocytes from Tumor Necrosis Factor-α Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis , 2004, Cancer Research.

[5]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[6]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[7]  J. T. Saari,et al.  Abrogation of Nuclear Factor-κB Activation Is Involved in Zinc Inhibition of Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production and Liver Injury , 2004 .

[8]  A. Datta,et al.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. , 2004, Genes & development.

[9]  M. Karin,et al.  The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.

[10]  Masayuki Yamamoto,et al.  Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. , 2004, Methods in enzymology.

[11]  S. Thorgeirsson,et al.  Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis. , 2004, Cancer research.

[12]  Jennifer Y. Zhang,et al.  NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. , 2004, Genes & development.

[13]  Michael Karin,et al.  The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.

[14]  M. Karin,et al.  IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .

[15]  Takahiro Doi,et al.  NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death , 2003, The EMBO journal.

[16]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[17]  E. Wagner,et al.  Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.

[18]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[19]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[20]  R. Pierce,et al.  Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. , 2002, The American journal of pathology.

[21]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[22]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[23]  M. Mori,et al.  Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine , 2002, Oncogene.

[24]  M. Hayakari,et al.  Nrf2 transactivator-independent GSTP1-1 expression in "GSTP1-1 positive" single cells inducible in female mouse liver by DEN: a preneoplastic character of possible initiated cells. , 2002, Carcinogenesis.

[25]  M. Karin,et al.  Inhibition of JNK activation through NF-κB target genes , 2001, Nature.

[26]  S. Thorgeirsson,et al.  Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. , 2001, Cancer research.

[27]  Y. Liaw,et al.  Constitutive activation of nuclear factor κB in hepatocellular carcinoma , 2000 .

[28]  S. Thorgeirsson,et al.  Transgenic mouse models in carcinogenesis research and testing. , 2000, Toxicology letters.

[29]  S. Thorgeirsson,et al.  Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[31]  A. Hara,et al.  Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice , 2000, British Journal of Cancer.

[32]  N. Fausto.  Liver regeneration. , 2000, Journal of hepatology.

[33]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[34]  N. Fausto,et al.  Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease , 1999, Seminars in liver disease.

[35]  M. Kay,et al.  The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors , 1997, Journal of virology.

[36]  J. Peschon,et al.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Williams,et al.  N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. , 1996, Pharmacology & therapeutics.

[38]  F. Chisari.  Hepatitis B virus transgenic mice: Insights into the virus and the disease , 1995, Hepatology.

[39]  A. Groen,et al.  Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. , 1994, The American journal of pathology.

[40]  U. Schibler,et al.  The 5' flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. , 1994, Nucleic acids research.

[41]  Gary M Williams,et al.  Inhibition of Chemical-Induced Experimental Cancer by Synthetic Phenolic Antioxidants , 1993, Toxicology and industrial health.

[42]  P. Schirmacher,et al.  The role of Ito cells in the biosynthesis of HGF-SF in the liver. , 1993, EXS.

[43]  C. Hulstaert,et al.  Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulation , 1992, Journal of leukocyte biology.

[44]  S. Korsmeyer,et al.  Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.

[45]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[46]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.

[47]  D. Goeddel,et al.  Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.

[48]  P. M. Rao,et al.  Liver tumour promotion by chemicals: models and mechanisms. , 1986, Cancer surveys.

[49]  J. Swenberg,et al.  Correlation of O4-ethyldeoxythymidine accumulation, hepatic initiation and hepatocellular carcinoma induction in rats continuously administered diethylnitrosamine. , 1986, Carcinogenesis.

[50]  G. Klein,et al.  Evolution of tumours and the impact of molecular oncology , 1985, Nature.

[51]  J. Farber,et al.  Mechanisms of cell injury with hepatotoxic chemicals. , 1984, Pharmacological reviews.

[52]  S. Sell,et al.  An Evaluation of Cellular Lineages in the Pathogenesis of Experimental Hepatocellular Carcinoma , 2007, Hepatology.

[53]  J. Taylor,et al.  Changes in rat alpha 1-fetoprotein and albumin mRNA levels during fetal and neonatal development. , 1980, The Journal of biological chemistry.

[54]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[55]  I. Berenblum.  Carcinogenesis and tumor pathogenesis. , 1954, Advances in cancer research.